Author: Ria Lassaunière; Anders Frische; Zitta B Harboe; Alex CY Nielsen; Anders Fomsgaard; Karen A Krogfelt; Charlotte S Jørgensen
Title: Evaluation of nine commercial SARS-CoV-2 immunoassays Document date: 2020_4_10
ID: 8cg5yj20_18
Snippet: In the early phase, the Wantai Total Ab ELISA had a sensitivity of 71% that plateaued at 100% after 10 days of illness duration. The IgG ELISA had the lowest sensitivity at all three phases that showed a distinct increase with each consecutive phase i.e. 43% in the early phase, 67% in the middle phase, and 78% in the late phase......
Document: In the early phase, the Wantai Total Ab ELISA had a sensitivity of 71% that plateaued at 100% after 10 days of illness duration. The IgG ELISA had the lowest sensitivity at all three phases that showed a distinct increase with each consecutive phase i.e. 43% in the early phase, 67% in the middle phase, and 78% in the late phase.
Search related documents:
Co phrase search for related documents- distinct increase and early phase: 1
- distinct increase and late phase: 1
- early phase and illness duration: 1, 2, 3, 4
- early phase and late phase: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- early phase and low sensitivity: 1, 2, 3, 4, 5
- early phase and middle phase: 1, 2, 3, 4, 5, 6, 7, 8, 9
- illness duration and late phase: 1
- late phase and low sensitivity: 1, 2
- late phase and middle phase: 1, 2, 3, 4, 5, 6
Co phrase search for related documents, hyperlinks ordered by date